US › Healthcare

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

US · Healthcare · Medical Instruments & Supplies

$1.73+8.12%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$26,790

Net profit

$-2.7M

EPS

$-0.10

EPS estimate

$0.00

Net margin

-10,039.2%

Key statistics

Market cap

$8.0M

Forward P/E

0.0

P/B

1.95

Book value

$1.49

EPS (TTM)

$-1.48

52-week high

$12.40

52-week low

$1.76

50-day MA

$3.60

200-day MA

$3.43

Shareholding

Institutions

5.05%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.17%
XTX Topco Ltd	0.17%
UBS Group AG	0.00%
Prospect Financial Group LLC	0.00%
TWO SIGMA SECURITIES, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.